表紙
市場調査レポート

世界の医薬品製造、研究開発、パッケージング受託市場:北米

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America

発行 BCC Research 商品コード 210429
出版日 ページ情報 英文 189 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
世界の医薬品製造、研究開発、パッケージング受託市場:北米 Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America
出版日: 2011年09月08日 ページ情報: 英文 189 Pages
概要

世界の医薬品製造・研究開発受託市場は2010年に1,965億米ドルの収益を上げ、2011年には2,179億米ドル、2016年までに3,606億米ドルに達すると予測されています。北米の2009年の製造受託におけるバルク剤収益は88億米ドル、2010年に97億米ドルとなりました。今後5年で166億米ドルになると予測されています。

当レポートでは、世界および北米の医薬品製造、研究開発、パッケージングの受託市場について調査分析し、サービスの概要、法規制の側面、業界構造、技術移転と新規開発に関する契約、応用分野、および参入企業のプロファイルなどをまとめ、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 定義
  • アウトソーシングの歴史

第4章 医薬品製造受託概要

  • 製造受託機関の種類
  • 製造受託経路
    • 要件
    • 融通性
    • コストを除く能力
  • 製造受託の長所と短所
  • 受託製造機関の選定
  • 製造受託に関する追加的事実
    • 場所と近接性
    • アフターサポート

第5章 医薬品研究開発受託の概要

  • CROが提供するサービス
  • CROの選定
  • CROが提供する研究

第6章 パッケージング受託の概要

  • パッケージング業者の必要性
  • パッケージング業者の選定
  • 受託機関の雇用
  • パッケージングの種類

第7章 プロジェクトマネジメント

  • プロジェクトマネジメントの仕様
  • プロジェクトマネジメントのプロセス
  • 関連因子
  • プロジェクトマネージャーの役割
  • 技術移転

第8章 法規制の側面

  • 警告文
  • 法規制の承認

第9章 北米の業界構造

  • 業界リーダーの市場シェア
  • バルク剤とAPIの製造受託機関
  • 固形剤の製造受託機関
  • 液剤の製造受託機関
  • 非滅菌品
  • 滅菌品
  • 半液体材料の製造受託機関
  • 研究受託会社

第10章 技術移転

  • 技術移転の理由
  • 技術移転中の問題
  • 技術移転
  • 成功する技術移転の手続き
  • 技術移転で用いられる契約の種類
    • 機密保持契約
    • 材料移転契約
    • ライセンス契約
    • 共同開発・共同マーケティング契約
  • 成功するプロジェクトの特性

第11章 新規開発

  • LONZA
  • ABBOTT
  • HOSPIRA
  • COVIDIEN
  • その他

第12章 北米市場分析

  • 製造受託
    • バルク剤/APIの製造受託
    • 経口薬の製造受託
    • 液剤の製造受託
    • 最新ドラッグデリバリー製品
    • OTC・栄養製品
  • 医薬品研究開発受託
  • 医薬品パッケージング受託

第13章 地域別市場シェア

第14章 北米市場における製造受託の応用分野

  • 心血管
  • 生殖薬剤
  • 鎮痛剤
  • 抗生物質
  • その他

第15章 特許分析

第16章 現在の環境

第17章 企業プロファイル

第18章 付録

目次
Product Code: PHM103A

Abstract

REPORT HIGHLIGHTS

  • The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.
  • North American markets' revenue for bulk drugs in contract manufacturing in 2009 was about $8.8 billion and increased to about $9.7 billion in 2010. It is projected to reach $16.6 billion by 2016, for a 5-year CAGR of 9.4%.
  • The total market for solid dosage form contract manufacturing in 2010 was valued at about $9.1 billion. This is expected to reach $10 billion by 2011 and forecasted to cross $16.1 billion by the end of 2016 at a CAGR of 10% for the five year period.

image1

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVE

The objective of BCC Research in conducting this study is to provide an overview of the current situation and future capabilities of the global pharmaceutical contract manufacturing, research, and packaging markets. The study provides a global as well as a regionally specific market overview. The report emphasizes the current and future outlook of the pharmaceutical contract manufacturing market, with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.

The current report discusses and outlines the current capabilities as well as the needs of the pharmaceutical contract manufacturing, research, and packaging markets. In addition, it discusses company and market strategies to further enhance the market. The report includes the different types of contract manufacturing and, more specifically, the services offered by global contract manufacturers, researchers, and packagers. The report also discusses the methods best used to identify an effective contract manufacturer as well as the advantages of contract manufacturing and outsourcing. The report highlights the need for project management, provides market forecasts for different aspects of contract manufacturing specific to each region, and examines the role of market leaders in the industry. Regulatory requirements and new developments in the market are also discussed in the report.

The report encompasses the revenues gained from contract manufacturing in each specific market and in each specific region. Sales analysis was performed on specific categories of drugs and dosage forms including API/bulk drugs and solid, liquid, and semisolid dosage forms. Sales analyses were also performed on revenues gained from contract packaging and contract research. The sales figures discussed are for the examined period of 2009 to 2011. Sales figures were also forecast for the following 5-year period from 2011 through 2016.

Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are discussed in a separate section of this report.

REASONS FOR DOING THIS STUDY

The majority of pharmaceutical companies are now using contract manufacturing, research, and packaging services. To save costs and product development time while simultaneously being effective, efficient, and productive, pharmaceutical companies are relying on contract manufacturers to fulfill many basic as well as specialized competencies. This study discusses the different types of contracting companies, their roles, and the share of the market they claim. New developments and new technologies warrant the issuing of this report, which is an important resource for anyone analyzing the discussed markets. Trends in outsourcing and new emerging markets for outsourcing are providing a new look to the market and greater options to pharmaceutical companies. The industry is seeing an increase in outsourcing as contract manufacturers, researchers, and packagers provide cheaper options as well as region-specific suppliers. The new state-of-the-art packaging facilities as well as expensive research facilities and capabilities of research organizations are enhancing the overall growth of the contract manufacturing industry. Contract manufacturers are providing pharmaceutical companies with expertise in all forms that the companies do not have available in-house.

INTENDED AUDIENCE

This study examines the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Strategic decision makers at biochemical and biotechnology companies, physicians, pharmaceuticals and biopharmaceuticals companies, and related research companies will find value in this study.

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications for contract manufacturing by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Market sizing estimates and projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master' s degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants, and Devices; Imaging Reagents; Regulatory Industry; Dynamic Sera, Media, and Reagents Used in Biotechnology; Contract Pharmaceutical Manufacturing, Research, and Packaging; Chiral Technology: Global Markets; Autacoids, and Related Drugs; Contraceptives; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs, and Devices; Cancer Therapies: Technologies and Global Market; and Medical Imaging Reagents and Analysis Equipment.

The lead consultant for this project was Ms. Taruna Chhabra, who holds a bachelor' s degree in biology and is a member of the National Honor Society for Biological Sciences.

Table of Contents

Chapter- 1: INTRODUCTION - Complimentary

  • STUDY OBJECTIVE
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter- 2: SUMMARY

  • Table 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
  • Figure 0 : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016

Chapter- 3: OVERVIEW

  • DEFINITIONS
  • HISTORY OF OUTSOURCING
    • Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING

Chapter- 4: OVERVIEW OF CONTRACT MANUFACTURING

  • TYPES OF CONTRACT MANUFACTURERS
  • CONTRACT MANUFACTURING TRAITS
  • ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
  • SELECTING A CONTRACT MANUFACTURER
  • ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING

Chapter- 5: OVERVIEW OF CONTRACT RESEARCH

  • SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
  • SELECTING A CONTRACT RESEARCH ORGANIZATION
  • RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONS
    • Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS

Chapter- 6: OVERVIEW OF CONTRACT PACKAGING

  • NEEDING A CONTRACT PACKAGER
  • SELECTING A CONTRACT PACKAGER
  • HIRING A CONTRACT PACKAGER
  • TYPES OF PACKAGING

Chapter- 7: PROJECT MANAGEMENT

  • SPECIFICATIONS OF PROJECT MANAGEMENT
  • PROCESSES OF PROJECT MANAGEMENT
  • FACTORS INVOLVED
  • ROLE OF THE PROJECT MANAGER
  • TECHNOLOGY TRANSFER
    • Table 14 : TECHNOLOGY TRANSFER STEPS

Chapter- 8: REGULATORY ASPECTS

  • WARNING LETTERS
  • REGULATORY APPROVALS
    • Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, JANUARY THROUGH MARCH, 2011
    • Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2010
    • Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2009

Chapter- 9: INDUSTRY STRUCTURE FOR NORTH AMERICA

  • MARKET SHARE OF INDUSTRY LEADERS
  • CONTRACT MANUFACTURERS OF BULK DRUGS AND API' S
  • CONTRACT MANUFACTURERS OF SOLID-DOSAGE FORMS
  • CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
  • CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
  • CONTRACT RESEARCH COMPANIES
  • CONTRACT PACKAGING COMPANIES
    • Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA 2010
    • Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA, 2010

Chapter- 10: TECHNOLOGY TRANSFER

  • REASONS FOR TECHNOLOGY TRANSFER
  • CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
  • TECHNOLOGY TRANSFER
  • TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
  • CHARACTERISTICS OF A SUCCESSFUL PROJECT

Chapter- 11: NEW DEVELOPMENTS

  • LONZA
  • ABBOTT
  • HOSPIRA
  • COVIDIEN
  • OTHER

Chapter- 12: MARKET ANALYSIS FOR NORTH AMERICA

  • CONTRACT MANUFACTURING
  • CONTRACT RESEARCH
  • CONTRACT PACKAGING

Chapter- 13: MARKET SHARE BY REGION

  • MARKET SHARE OF CONTRACT MANUFACTURED API' S
  • MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMS
  • MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGE FORMULATIONS
  • MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID DOSAGE FORMULATIONS
  • MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUG DELIVERY PRODUCTS
  • MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONAL PRODUCTS
  • MARKET SHARE OF CONTRACT RESEARCH
  • MARKET SHARE OF CONTRACT PACKAGING
    • Table 63 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
    • Figure 41 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010

Chapter- 14: CONTRACT MANUFACTURING APPLICATIONS FOR NORTH AMERICAN MARKETS

  • CARDIOVASCULAR DRUGS
  • REPRODUCTIVE DRUG MARKET
  • ONCOLOGY DRUG MARKET
  • ANALGESICS MARKET
  • ANTIVIRAL DRUG MARKET
  • ANTIBIOTICS MARKET
  • MARKETS FOR OTHER DRUGS

Chapter- 15: PATENT ANALYSIS

  • PATENTS BY YEAR
  • PATENTS BY COMPANY
  • PATENTS BY COUNTRY
  • PATENTS BY EMPHASIS
    • Table 75 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
    • Figure 54 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011

Chapter- 16: CURRENT ENVIRONMENT

  • SITUATION OF THE NORTH AMERICAN CONTRACTING MARKETS
  • SITUATION OF THE EUROPEAN CONTRACTING MARKET
  • SITUATION OF THE ROW CONTRACTING MARKET
  • OPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACT MANUFACTURING INDUSTRY

Chapter- 17: COMPANY PROFILES

  • AAI PHARMA, INC.
  • ABBOTT LABORATORIES
  • AEROGEN LTD.
  • ALKERMES
  • ALTHEA TECHNOLOGIES
  • AMCOR
  • AMERISOURCE BERGEN CORPORATION
  • AMPAC FINE CHEMICALS
  • ALBANY MOLECULAR RESEARCH INC. (AMRI)
  • AP PHARMA INC.
  • APTUIT INC.
  • ARADIGM CORPORATION
  • BASF SE
  • BAXTER HEALTHCARE
  • BCM/BOOTS MANUFACTURING
  • BOEHRINGER INGELHEIM
  • BRISTOL-MYERS SQUIBB
  • CAMBREX CORPORATION
  • CANGENE CORPORATION
  • CATALENT PHARMA SOLUTIONS
  • CEDARBURG HAUSER PHARMACEUTICALS INC.
  • CENEXI
  • CHARLES RIVER LABORATORIES
  • CHEMBRIDGE CORP.
  • CLEARSTONE CENTRAL LABORATORIES
  • CONFAB LABORATORIES
  • COVANCE INC.
  • COVIDIEN
  • CONTRACT PHARMACEUTICALS LIMITED
  • CORDEN PHARMA SWITZERLAND LLC
  • DAVOS PHARMA
  • DECODE GENETICS
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
  • DOW CHEMICAL
  • DPT LABORATORIES INC.
  • DR. REDDY' S LABORATORIES
  • DSM PHARMACEUTICAL PRODUCTS
  • FUJIFILM DIOSYNTH BIOTECHNOLOGY
  • ELAN DRUG TECHNOLOGIES
  • EVOTEC AG
  • FULCRUM PHARMA PLC
  • GIRINDUS AG
  • GLAXOSMITHKLINE
  • HOSPIRA
  • HAUPT PHARMA AG
  • HOVIONE S.A.
  • ICON PLC
  • INC RESEARCH, INC.
  • JUBILANT LIFESCIENCES
  • KENDLE INTERNATIONAL INC.
  • KP PHARMACEUTICAL TECHNOLOGIES INC.
  • K.V. PHARMACEUTICAL CO.
  • LIGAND PHARMACEUTICALS, INC.
  • LONZA GROUP
  • LYNE LABORATORIES
  • MERCK / MSD BIOMANUFACTURING NETWORK
  • MIKART INC
  • NEXTPHARMA TECHNOLOGIES
  • NORWICH PHARMACEUTICALS
  • NOVAVAX, INC.
  • OMNICARE CLINICAL RESEARCH
  • PAREXEL INTERNATIONAL CORPORATION
  • PATHEON INC.
  • PERRIGO COMPANY
  • PFIZER (KING PHARMACEUTICALS
  • PIRAMAL HEALTHCARE LIMITED
  • PPD
  • PRA INTERNATIONAL
  • QUINTILES
  • RANBAXY
  • REGIS TECHNOLOGIES, INC.
  • SKYEPHARMA
  • TALECRIS BIOTHERAPEUTICS INC.
  • VETTER PHARMA INTERNATIONAL GMBH
  • WOCKHARDT LIMITED
  • WUXI APP TEC
  • XCELLEREX LLC
  • ZACH SYSTEM S.P.A

Chapter- 18: APPENDIX I: ABBREVIATIONS

List of Tables

  • Summary Table : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016
  • Table 1 : KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
  • Table 2 : KEY ADVANTAGES OF CONTRACT MANUFACTURING
  • Table 3 : KEY DISADVANTAGES OF CONTRACT MANUFACTURING
  • Table 4 : KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
  • Table 5 : SERVICES OF CONTRACT RESEARCH ORGANIZATIONS
  • Table 6 : KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCH ORGANIZATION
  • Table 7 : TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
  • Table 8 : REASONS BEHIND NEEDING A CONTRACT PACKAGER
  • Table 9 : KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGER
  • Table 10 : KEY STEPS IN HIRING A CONTRACT PACKAGER
  • Table 11 : STEPS OF PROJECT MANAGEMENT
  • Table 12 : PROCESSES OF PROJECT MANAGEMENT
  • Table 13 : KEY RESPONSIBILITIES OF PROJECT MANAGERS
  • Table 14 : TECHNOLOGY TRANSFER STEPS
  • Table 15 : REGULATED FACTORS OF CMO' S AND CRO' S
  • Table 16 : TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT MANUFACTURING
  • Table 17 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2010
  • Table 18 : WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2009
  • Table 19 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, JANUARY THROUGH MARCH, 2011
  • Table 20 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2010
  • Table 21 : REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2009
  • Table 22 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API' S, IN NORTH AMERICA, 2010
  • Table 23 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Table 24 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Table 25 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Table 26 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Table 27 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA, 2010
  • Table 28 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA 2010
  • Table 29 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 30 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 31 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
  • Table 32 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Table 33 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 34 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 35 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
  • Table 36 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, FOR NORTH AMERICA, 2010
  • Table 37 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
  • Table 38 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Table 39 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 40 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016
  • Table 41 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Table 42 : CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
  • Table 43 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Table 44 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY FORMULATION, THROUGH 2016
  • Table 45 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, 2010
  • Table 46 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY CONTRACT MANUFACTURING, THROUGH 2016 ($ BILLIONS)
  • Table 47 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE BY FORMULATION FOR NORTH AMERICA, THROUGH 2016
  • Table 48 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Table 49 : CONTRACT RESEARCH REVENUE FOR NORTH AMERICA, THROUGH 2016
  • Table 50 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, THROUGH 2016
  • Table 51 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH AMERICA, 2010
  • Table 52 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, THROUGH 2016
  • Table 53 : CONTRACT PACKAGING REVENUE BY TYPE, FOR NORTH AMERICA, THROUGH 2016
  • Table 54 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA, 2010
  • Table 55 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 56 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 57 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 58 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 59 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY REGION, 2010
  • Table 60 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 61 : OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Table 62 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
  • Table 63 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
  • Table 64 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS, IN NORTH AMERICA, THROUGH 2016
  • Table 65 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN NORTH AMERICA, THROUGH 2016
  • Table 66 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN NORTH AMERICA, THROUGH 2016
  • Table 67 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH AMERICA, THROUGH 2016
  • Table 68 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH AMERICA, THROUGH 2016
  • Table 69 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH AMERICA, THROUGH 2016
  • Table 70 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH AMERICA, THROUGH 2016
  • Table 71 : NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011
  • Table 72 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
  • Table 73 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
  • Table 74 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
  • Table 75 : PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011

List of Figures

  • Summary Figure : GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016
  • Figure 1 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API' S, IN NORTH AMERICA, 2010
  • Figure 2 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Figure 3 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Figure 4 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Figure 5 : MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010
  • Figure 6 : MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH AMERICA, 2010
  • Figure 7 : MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH AMERICA, 2010
  • Figure 8 : BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
  • Figure 9 : SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
  • Figure 10 : SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATIONS, FOR NORTH AMERICA, 2009-2016
  • Figure 11 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR NORTH AMERICA, 2010
  • Figure 12 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
  • Figure 13 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Figure 14 : LIQUID DOSAGE FORM (NON STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
  • Figure 15 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Figure 16 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
  • Figure 17 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Figure 18 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH AMERICA, 2009-2016
  • Figure 19 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
  • Figure 20 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010
  • Figure 21 : ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016
  • Figure 22 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING REVENUE, BY FORMULATIONS, 2009-2016
  • Figure 23 : ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATIONS, 2010
  • Figure 24 : OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY CONTRACT MANUFACTURING, 2009-2016
  • Figure 25 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016
  • Figure 26 : OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR NORTH AMERICA, 2010
  • Figure 27 : CONTRACT RESEARCH REVENUE, FOR NORTH AMERICA, 2009-2016
  • Figure 28 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, 2009-2016
  • Figure 29 : CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH AMERICA, 2010
  • Figure 30 : CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, 2009-2016
  • Figure 31 : CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA, 2009-2016
  • Figure 32 : CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA, 2010
  • Figure 33 : BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 34 : SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 35 : LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 36 : LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 37 : SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 38 : DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 39 : OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARE, BY REGION, 2010
  • Figure 40 : CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010
  • Figure 41 : CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
  • Figure 42 : REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR DRUGS, IN NORTH AMERICA, 2009-2016
  • Figure 43 : REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE DRUGS, IN NORTH AMERICA, 2009-2016
  • Figure 44 : REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS, IN NORTH AMERICA, 2009-2016
  • Figure 45 : REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN NORTH AMERICA, 2009-2016
  • Figure 46 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN NORTH AMERICA, 2009-2016
  • Figure 47 : REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN NORTH AMERICA, 2009-2016
  • Figure 48 : REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN NORTH AMERICA, 2009-2016
  • Figure 49 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
  • Figure 50 : NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
  • Figure 51 : NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
  • Figure 52 : NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
  • Figure 53 : PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011
  • Figure 54 : NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
Back to Top